Traditional Chinese medicine composition for treating cerebral arteriosclerosis and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine composition for treating cerebral arteriosclerosis and a preparation method thereof. The traditional Chinese medicine composition comprises the following components in parts by weight: 18 parts of root of rehmannia, 13 parts of dragon's blood, 13 parts of ligusticum wallichii, 18 parts of borneol, 18 parts of radix polygonati officinalis, 12 parts of sticktight, 12 parts of dendrobe, 17 parts of leech, 13 parts of trogopterus dung, 13 parts of rhizoma typhonii, 13 parts of selfheal, 13 parts of eucommia ulmoides, 17 parts of achyranthes root, 17 parts of codonopsis pilosula, 13 parts of pinellia ternata, 17 parts of rhizoma zingiberis and 13 parts of poria. The preparation method comprises the following steps: taking raw medicinal materials in the formula, adding a proper amount of water, decocting with slow fire for about 40 minutes, filtering decoction dregs, and preparing the decoction. Clinical tests prove that the traditionalChinese medicine composition has no toxic or side effect, is obvious in curative effects and high in cure rate and has no adverse effect, internal organ functions of patients can be obviously improved, and particularly cardiac functions of the patients can be obviously improved.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating cerebral arteriosclerosis and a preparation method thereof. technical background [0002] Cardiovascular and cerebrovascular diseases such as coronary heart disease, arteriosclerosis, pulmonary heart disease, and multi-infarct dementia are mostly middle-aged and elderly people, and require long-term medication. In the Pharmacopoeia of the People's Republic of China, Lemai Granules and the existing Lemai Tablet oral solid preparations correspond to elderly people who have difficulty swallowing and take a long time to reach the effective blood concentration. However, the present invention overcomes the above disadvantages and has the advantages of small dosage, good taste, convenient taking, fast absorption and high bioavailability. Contents of the invention [0003] The purpose of the invention is to provide a traditiona...

AI Technical Summary

Problems solved by technology

According to the Pharmacopoeia of the People's Republic of China, Lemai Granules and the existing Lemai Tablet oral solid preparations correspond to elderly people who have difficulty swallowing and take a long time to reach the effective blood concentration.